Bio-Path (BPTH) Set to Announce Quarterly Earnings on Friday

Bio-Path (NASDAQ:BPTH) is set to announce its earnings results before the market opens on Friday, November 15th. Analysts expect the company to announce earnings of ($1.02) per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Bio-Path (NASDAQ:BPTH) last announced its quarterly earnings results on Thursday, August 15th. The company reported ($1.16) earnings per share for the quarter, beating the consensus estimate of ($1.54) by $0.38. During the same period in the previous year, the firm earned ($10.60) EPS. On average, analysts expect Bio-Path to post $-6 EPS for the current fiscal year and $-4 EPS for the next fiscal year.

Bio-Path Stock Performance

Bio-Path stock opened at $0.88 on Thursday. The stock’s 50 day simple moving average is $0.99 and its two-hundred day simple moving average is $1.61. Bio-Path has a 12 month low of $0.80 and a 12 month high of $12.40.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on shares of Bio-Path in a research report on Friday, November 8th. They issued a “sell” rating for the company.

Bio-Path Company Profile

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.